Mutations in context: implications of BRCA testing in diverse populations Gabriela E. S. FelixYonglan ZhengOlufunmilayo I. Olopade Original Article 16 September 2017 Pages: 471 - 483
Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery Rachel ShapiraErin TurbittGillian W. Hooker Original Article 05 December 2017 Pages: 485 - 493
Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk Allison H. WestKathleen R. BlazerOlufunmilayo I. Olopade Original Article 14 February 2018 Pages: 495 - 505
SNP association study in PMS2-associated Lynch syndrome Sanne W. ten BroekeFadwa A. ElsayedMaartje Nielsen Original Article Open access 17 November 2017 Pages: 507 - 515
Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients Kazuya InokiTakeshi NakajimaYutaka Saito Original Article 30 November 2017 Pages: 517 - 524
Urological sequelae of desmoids associated with familial adenomatous polyposis S. J. WaltonG. MalietzisE. Havranek Original Article 27 February 2018 Pages: 525 - 530
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation Jenny von SaloméTao LiuKristina Lagerstedt-Robinson Original Article Open access 29 December 2017 Pages: 531 - 537
APC mosaicism in a young woman with desmoid type fibromatosis and familial adenomatous polyposis Astrid Tenden StormorkenThomas BergEli Marie Grindedal Original Article Open access 24 January 2018 Pages: 539 - 543
Response to letter to editor regarding published article—metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis Mark P. LythgoeSalim S. MalikKevin J. Monahan Letter to the Editor 15 February 2018 Pages: 545 - 546
Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline Anaita Kanga-ParabiaClara GaffLouise A. Keogh Original Article 20 February 2018 Pages: 547 - 555
Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis Salim S. MalikMark P. LythgoeKevin J. Monahan Original Article Open access 30 November 2017 Pages: 557 - 564
Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers Fay KastrinosHajime UnoSapna Syngal Letter to the Editor 29 January 2018 Pages: 567 - 567
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma Marieke HylebosKen Op de BeeckGuy Van Camp Original Article 30 June 2018 Pages: 569 - 576
Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer Qin LiTielong TangLin Zhang Original Article 08 November 2017 Pages: 577 - 585
Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation Carolina Arenas ValenciaLiliana Lopez KleineClara E. Arteaga Diaz Original Article 04 January 2018 Pages: 587 - 599
Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same A. J. HuqM. WalshI. M. Winship Original Article 22 January 2018 Pages: 601 - 606
The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome Shelley MacaulayQuintin Clive GoodyearAmanda Krause Original Article 01 February 2018 Pages: 607 - 613
A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC) Priya T. BholaCathy GilpinGail E. Graham Original Article 08 February 2018 Pages: 615 - 620
Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience Eliza CourtneyXin Wei ChinJoanne Ngeow Short Communication 24 January 2018 Pages: 621 - 626